- recruitingPHASE3
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer
This study looks at treating advanced prostate cancer with hormone tablets. Researchers want to see if a lower dose works as well as the standard dose, with fewer side effects like tiredness. It aims to improve quality of life for patients.
United Kingdom - active not recruitingPHASE3
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
This study looks at a new combination treatment, talazoparib and enzalutamide, for men with advanced prostate cancer that has spread and become resistant to hormone therapy. We want to see if this combination works better than enzalutamide alone.
United States · Argentina · Australia - recruitingPHASE1, PHASE2
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
This study is testing a new treatment for advanced prostate cancer that has spread and isn't responding to usual hormone therapy. It's called 177Lu-rhPSMA-10.1 and uses radiation to target cancer cells. We want to see how safe and effective it is.
United States · Belgium · Germany